Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson's disease

Young Eun Kim; Han Joon Kim; Ji Young Yun; Beom S. Jeon

doi:10.1007/s00415-011-6083-0

Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson's disease

Young Eun Kim, Han Joon Kim, Ji Young Yun, Beom S. Jeon

Department of Neurology

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	2274-2275
Number of pages	2
Journal	Journal of Neurology
Volume	258
Issue number	12
DOIs	https://doi.org/10.1007/s00415-011-6083-0
State	Published - Dec 2011

Bibliographical note

Funding Information:
Y.E.K. and B.S.J had full access to the data in the study and had final responsibility for the decision to submit for publication. This study is not related with any financial support. B.S.J. has received funding for travel from Novartis Korea; and has received research support as PI from Norvatis, Boehringer Ingelheim, the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (#A030001), ABRC (Advanced Biometric Research Center). KOSEF (Korean Science and Engineering Foundation), Seoul National University Hospital, the Mr. Chung Suk-Gyoo and Sinyang Cultural Foundation, and the Song Foundation. J.Y.Y. reports no disclosures. H.J.K. reports no disclosures. Y.E.K. reports no disclosures.

Access to Document

10.1007/s00415-011-6083-0

Cite this

@article{ee4633b22a9b40bd9f6a0a6a5ee45fb4,

title = "Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson's disease",

author = "Kim, {Young Eun} and Kim, {Han Joon} and Yun, {Ji Young} and Jeon, {Beom S.}",

note = "Funding Information: Y.E.K. and B.S.J had full access to the data in the study and had final responsibility for the decision to submit for publication. This study is not related with any financial support. B.S.J. has received funding for travel from Novartis Korea; and has received research support as PI from Norvatis, Boehringer Ingelheim, the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (#A030001), ABRC (Advanced Biometric Research Center). KOSEF (Korean Science and Engineering Foundation), Seoul National University Hospital, the Mr. Chung Suk-Gyoo and Sinyang Cultural Foundation, and the Song Foundation. J.Y.Y. reports no disclosures. H.J.K. reports no disclosures. Y.E.K. reports no disclosures. ",

year = "2011",

month = dec,

doi = "10.1007/s00415-011-6083-0",

language = "English",

volume = "258",

pages = "2274--2275",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "D. Steinkopff-Verlag",

number = "12",

}

TY - JOUR

T1 - Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson's disease

AU - Kim, Young Eun

AU - Kim, Han Joon

AU - Yun, Ji Young

AU - Jeon, Beom S.

N1 - Funding Information: Y.E.K. and B.S.J had full access to the data in the study and had final responsibility for the decision to submit for publication. This study is not related with any financial support. B.S.J. has received funding for travel from Novartis Korea; and has received research support as PI from Norvatis, Boehringer Ingelheim, the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (#A030001), ABRC (Advanced Biometric Research Center). KOSEF (Korean Science and Engineering Foundation), Seoul National University Hospital, the Mr. Chung Suk-Gyoo and Sinyang Cultural Foundation, and the Song Foundation. J.Y.Y. reports no disclosures. H.J.K. reports no disclosures. Y.E.K. reports no disclosures.

PY - 2011/12

Y1 - 2011/12

UR - http://www.scopus.com/inward/record.url?scp=83255186694&partnerID=8YFLogxK

U2 - 10.1007/s00415-011-6083-0

DO - 10.1007/s00415-011-6083-0

M3 - Letter

C2 - 21547378

AN - SCOPUS:83255186694

SN - 0340-5354

VL - 258

SP - 2274

EP - 2275

JO - Journal of Neurology

JF - Journal of Neurology

IS - 12

ER -